U.S. biotech Celgene raises forecast as profit beats Street
 

U.S. biotech Celgene raises forecast as profit beats Street
(Reuters) - U.S. biotech**logy company Celgene Corp reported a better-than-expected quarterly profit and raised its adjusted earnings forecast for 2016 due to higher demand for its key multiple myeloma drug, Revlimid.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...tM:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...tM:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/_O1F1mK6Taw